Supreme Court of Canada to decide upon sufficiency of Viagra's disclosure

Abstract

The Supreme Court of Canada must decide whether the disclosure provided for in Pfizer’s Canadian patent no. 2,163,446 (better known as the Viagra patent) was sufficient. Teva v. Pfizer, [2010] SCCA No 443 is one of the few patent cases on the Supreme Court’s docket, and the decision will be highly anticipated. Canada’s top Court will have to address the impo(r)tence of Pfizer’s specification and certainly cannot shy away from the hard issues.